break out above 200DMA with volume… on results…
margin jump
company : "Novartis India "
Novartis India reported huge jump in net profit and margin due to cut in employee costs (layoffs) and improvement in sales… as they have stuck a sales and distribution deal for some of their their branded portfolio of drugs with Dr Reddy labs “calicium sandoz” “diclofenac”…
source:Portfolio under Novartis-Dr Reddy’s agreement comprises over 30% of NIL’s turnover
extract form annual report.
“The Company has entered into an exclusive
sales and distribution arrangement for few
of its Established Medicines brands with
Dr. Reddy’s. This arrangement aims to
further broaden access of these medicines
beyond the current geographies to benefit
many more patients, more efficiently,
by significantly extending the reach of
healthcare professionals through an expanded
field force.”
@hitesh2710
Sir, my question…Can we see this as some kind of earnings based pivot to the upside in this neglected company with an improvement in ROCE, NPM profile along with sales due to the partnership with dr Reddy … ? can this leading to a new 52 week high ? thanks…